Takeda Pharmaceutical (TAK) Short-Term Debt issuances (2018 - 2025)

Takeda Pharmaceutical's Short-Term Debt issuances history runs 7 years deep, the most recent figure standing at $2.3 billion for Q1 2025.

• In Q1 2025, Short-Term Debt issuances changed N/A year-over-year to $2.3 billion; the TTM figure through Mar 2025 stood at $137.6 million (changed N/A YoY), while the FY2026 annual figure was -$2.3 billion, down 1358.13% from the prior year.
• Short-Term Debt issuances for Q1 2025 stood at $2.3 billion, up from -$2.0 billion in the prior quarter.
• The five-year high for Short-Term Debt issuances was $2.3 billion in Q1 2025, with the low at -$2.0 billion in Q3 2024.
• The 4-year median for Short-Term Debt issuances is $401.3 million (2021), against an average of $348.4 million.
• The sharpest annual moves came in 2021 and 2024: Short-Term Debt issuances jumped 100.01% in 2021, then tumbled 113.61% in 2024.
• Takeda Pharmaceutical's Short-Term Debt issuances stood at $9135.0 in 2021, then soared by 12589798.96% to $1.2 billion in 2023, then sank by 274.88% to -$2.0 billion in 2024, then soared by 212.27% to $2.3 billion in 2025.
• Business Quant data shows TAK's Short-Term Debt issuances at $2.3 billion in Q1 2025, -$2.0 billion in Q3 2024, and -$109.2 million in Q2 2024.